RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
Rui Kang(Research Institute of Petroleum Exploration and Development), Herbert J. Zeh(Southwestern Medical Center)
Cited by 91
Related Papers
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)
|Clinical Cancer Research|2019|260
Oxidative stress-mediated HMGB1 biology
|Frontiers in Physiology|2015|255
A guideline on the molecular ecosystem regulating ferroptosis
|Nature Cell Biology|2024|251
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer
|Cell Research|2017|135